Street Calls of the Week
Christopher J. Joyce, Chief Legal and Admin. Officer at Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 30,939 shares of common stock on September 10, 2025, for approximately $507,635. The transaction comes as ALHC shows strong momentum, with the stock up over 46% year-to-date and trading near its InvestingPro Fair Value.
The sales were executed in two tranches. The first involved 22,128 shares sold at a weighted average price of $16.2293, with individual prices ranging from $15.74 to $16.735. The second transaction involved 8,811 shares at a weighted average price of $16.8555, with prices ranging from $16.74 to $17.24. The current stock price of $16.45 sits well above its 52-week low of $8.82, reflecting the company’s strong market performance.
Following these transactions, Joyce directly owns 343,592 shares of Alignment Healthcare, Inc.
The sales were to cover tax withholding obligations related to the vesting of restricted stock units and do not represent a discretionary trade.
In other recent news, Alignment Healthcare reported its second-quarter 2025 earnings, revealing an earnings per share (EPS) of $0.07, which significantly surpassed the forecast of -$0.07. The company’s revenue reached $1 billion, exceeding the anticipated $960.51 million, highlighting strong business growth. Following this solid earnings report, Barclays upgraded Alignment Healthcare’s stock rating from Underweight to Equalweight and raised its price target from $9.00 to $13.00. Additionally, KeyBanc upgraded the stock from Sector Weight to Overweight, citing a positive growth outlook and a price target of $21.00.
These upgrades reflect confidence in Alignment Healthcare’s platform, which is noted for improving hospital utilization and reinvesting savings into member benefits. In another development, the company announced the appointment of Matt Eyles as executive vice president of government and business strategy. Eyles will focus on enhancing engagement in healthcare policy and leading business planning to adapt to industry changes. These recent developments indicate a period of significant activity and strategic growth for Alignment Healthcare.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.